Selumetinib Fails to Improve Outcomes With Dacarbazine in Uveal Melanoma
The combination of selumetinib with dacarbazine did not offer improved survival outcomes over placebo/dacarbazine in patients with metastatic uveal melanoma. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Melanoma News Source Type: news
Study shows need for early support among people with uveal melanoma
FINDINGSUCLA researchers found that nearly all people diagnosed with uveal melanoma had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses. The study is the first to examine long-term supportive care needs among patients with this disease, and suggested there are more acute needs among people with uveal melanoma than people with other cancers. Social and psychological circumstances that affect these patients, such as personality factors, the social support they receive and the size of their social network, contributed more to a greater need for sup...
Source: UCLA Newsroom: Health Sciences - March 5, 2018 Category: Universities & Medical Training Source Type: news
Life- and Eye-Saving New Treatments for Uveal Melanoma Life- and Eye-Saving New Treatments for Uveal Melanoma
Gene testing and immunotherapy have opened the door to treatments that could save the eyesight and the lives of people with uveal melanoma.Medscape Medical News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - September 15, 2017 Category: Opthalmology Tags: Ophthalmology News Source Type: news
Breakthrough Treatments Arriving for Uveal Melanoma Breakthrough Treatments Arriving for Uveal Melanoma
Gene testing and immunotherapy have opened the door to treatments that could save the eyesight and the lives of people with uveal melanoma.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Eye-Saving New Treatment Options for Uveal Melanoma Eye-Saving New Treatment Options for Uveal Melanoma
Gene testing and immunotherapy have opened the door to treatments that could save the eyesight and the lives of people with uveal melanoma.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 14, 2017 Category: Pathology Tags: Ophthalmology News Source Type: news
Genetic Glitches in Uveal Melanoma: Ophthalmology Times
(MedPage Today) -- Also, the limits of anti-VEGF therapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 22, 2017 Category: Hematology Source Type: news
Georgia State's Inlighta Biosciences gets $2 million grant to develop enhanced MRI contrast agents
(Georgia State University) A local start-up, life sciences company founded by Dr. Jenny Yang, Regents' Professor of Biochemistry at Georgia State University, has received a $2 million federal grant to develop improved magnetic resonance imaging (MRI) contrast agents for the early detection of liver cancers and other cancers, such as uveal melanoma or eye cancer, that have metastasized to the liver. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2017 Category: International Medicine & Public Health Source Type: news
Adoptive T-Cell Therapy Induced Response in Metastatic Uveal Melanoma
More than one-third of patients with metastatic uveal melanoma had objective tumor regression when treated with adoptive transfer of autologous tumor-infiltrating lymphocytes. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Melanoma News Source Type: news
Emerging Therapies for Uveal Melanoma: Ophthalmology Times
(MedPage Today) -- Also: avoiding ruptures during deep anterior lamellar keratoplasty (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 2, 2017 Category: American Health Source Type: news
Metastatic Disease From Uveal Melanoma Metastatic Disease From Uveal Melanoma
What treatment options are available for patients who develop metastatic disease from this type of ocular melanoma?The British Journal of Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Increased eye cancer risk linked to pigmentation genes that dictate eye color
New research links specific inherited genetic differences to an increased risk for eye (uveal) melanoma, a rare form of melanoma that arises from pigment cells that determine eye color. scientists report the first evidence of a strong association between genes linked to eye color and development of uveal melanoma. Reported data suggests that inherited genetic factors associated with eye and skin pigmentation could increase a person ' s risk for uveal melanoma. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 19, 2016 Category: Science Source Type: news
Increased eye cancer risk linked to pigmentation genes that dictate eye color
(Ohio State University Wexner Medical Center) New research links specific inherited genetic differences to an increased risk for eye (uveal) melanoma, a rare form of melanoma that arises from pigment cells that determine eye color. scientists report the first evidence of a strong association between genes linked to eye color and development of uveal melanoma. Reported data suggests that inherited genetic factors associated with eye and skin pigmentation could increase a person's risk for uveal melanoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 19, 2016 Category: Global & Universal Source Type: news
European H2020 grant to fight eye cancer for the next 5 years
(JLM&A, SA ) UM Cure 2020 is a new European Consortium to foster research on metastatic uveal melanoma and identify new treatments for this serious disease.Under the coordination of Institut Curie in Paris, the Consortium involving 12 partners has received 6 million euros of funding from the European Union's Horizon 2020 research and innovation program to identify new therapeutic approaches to treat metastatic uveal melanoma in a five-year project. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2016 Category: Global & Universal Source Type: news
[Editors' Choice] One target to quench many
Inhibiting the GTPase ARF6 chokes the diverse output of mutant Gαq proteins in uveal melanoma. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - June 29, 2016 Category: Science Authors: Nancy Gough (mailto:ngough at aaas.org) Source Type: news
Researchers Make Progress in Unraveling Uveal MelanomaResearchers Make Progress in Unraveling Uveal Melanoma
Two studies from the University of Miami Miller School of Medicine shed light on physiological and genetic factors associated with uveal melanoma (UM). Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
